Confidence intervals for the selected population in randomized trials that adapt the population enrolled.
暂无分享,去创建一个
[1] J. Hájek. A characterization of limiting distributions of regular estimates , 1970 .
[2] Ennis,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[3] Sue-Jane Wang,et al. Adaptive patient enrichment designs in therapeutic trials , 2009, Biometrical journal. Biometrische Zeitschrift.
[4] B. Turnbull,et al. Repeated confidence intervals for group sequential clinical trials. , 1984, Controlled clinical trials.
[5] F. Götze. On the Rate of Convergence in the Multivariate CLT , 1991 .
[6] Christopher Jennison,et al. Adaptive Seamless Designs: Selection and Prospective Testing of Hypotheses , 2007, Journal of biopharmaceutical statistics.
[7] Jon A. Wellner,et al. Weak Convergence and Empirical Processes: With Applications to Statistics , 1996 .
[8] T. Fleming,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[9] Martin Posch,et al. Testing and estimation in flexible group sequential designs with adaptive treatment selection , 2005, Statistics in medicine.
[10] W. Brannath,et al. Estimation in flexible two stage designs , 2006, Statistics in medicine.
[11] Blair T. Johnson,et al. Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration , 2008, PLoS medicine.
[12] W. Lehmacher,et al. Adaptive Sample Size Calculations in Group Sequential Trials , 1999, Biometrics.
[13] E. Russek-Cohen,et al. Evaluating treatments when a gender by treatment interaction may exist. , 1997, Statistics in medicine.
[14] Dean Follmann,et al. ADAPTIVELY CHANGING SUBGROUP PROPORTIONS IN CLINICAL TRIALS , 1997 .
[15] Allan R Sampson,et al. Drop‐the‐Losers Design: Normal Case , 2005, Biometrical journal. Biometrische Zeitschrift.
[16] Mark C. K. Yang,et al. Interval estimation for drop-the-losers designs , 2010 .
[17] Sue-Jane Wang,et al. Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset , 2007, Pharmaceutical statistics.
[18] M. J. van der Laan,et al. Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment. , 2011, Biometrika.